BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11527132)

  • 1. Beta-adrenoceptor-blocking drugs in the elderly.
    Tregaskis BF; McDevitt DG
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S25-8. PubMed ID: 11527132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
    Prichard BN; Saul PA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.
    Piepho RW; Fendler KJ
    Drugs Aging; 1991 May; 1(3):194-211. PubMed ID: 1686570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP; Giles TD; Sowers JR
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.
    Gavras I; Gavras H; Brunner HR; Liang CS
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):213S-217S. PubMed ID: 37876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Third generation beta blockers in the treatment of hypertension].
    Widimský J
    Vnitr Lek; 1992 May; 38(5):417-25. PubMed ID: 1354908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker therapy in heart failure in the elderly.
    Fu M
    Int J Cardiol; 2008 Apr; 125(2):149-53. PubMed ID: 18023898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA
    Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current position of beta-adrenergic blockers in the management of arterial hypertension].
    Rumboldt Z
    Lijec Vjesn; 2007; 129(6-7):237-40. PubMed ID: 18018716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antihypertensive treatment with beta-blockers on glucose metabolism.
    Sawicki PT; Berger M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S45-7; discussion S47-8. PubMed ID: 1284143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges for beta-blockers as first-line therapy for elderly hypertensive patients.
    Prisant LM
    Postgrad Med; 2002 Dec; 112(6 Suppl Heart):34-41. PubMed ID: 19667616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular protection using beta-blockers: a critical review of the evidence.
    Bangalore S; Messerli FH; Kostis JB; Pepine CJ
    J Am Coll Cardiol; 2007 Aug; 50(7):563-72. PubMed ID: 17692739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.